Triple-negative breast cancer (TNBC) is a subset of breast cancer that lacks the expression of estrogen receptor (ER) and progesterone receptor (PR), and has low level of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and triple-negative breast carcinoma.